Arrowstreet Capital’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-109,849
| Closed | -$1.98M | – | 2138 |
|
|
2025
Q1 | $1.98M | Buy |
109,849
+34,111
| +45% | +$606K | ﹤0.01% | 1299 |
|
|
2024
Q4 | $1.32M | Sell |
75,738
-491,942
| -87% | -$6.65M | ﹤0.01% | 1387 |
|
|
2024
Q3 | $6.53M | Sell |
567,680
-218,958
| -28% | -$2.51M | 0.01% | 884 |
|
|
2024
Q2 | $8.9M | Sell |
786,638
-167,637
| -18% | -$2.23M | 0.01% | 676 |
|
|
2024
Q1 | $13.7M | Buy |
954,275
+759,395
| +390% | +$10.8M | 0.01% | 597 |
|
|
2023
Q4 | $2.67M | Buy |
+194,880
| New | +$2.05M | ﹤0.01% | 900 |
|
|
2023
Q2 | – | Sell |
-125,882
| Closed | -$1.01M | – | 1521 |
|
|
2023
Q1 | $1.01M | Sell |
125,882
-27,646
| -18% | -$284K | ﹤0.01% | 1063 |
|
|
2022
Q4 | $1.74M | Sell |
153,528
-2,930
| -2% | -$32K | ﹤0.01% | 905 |
|
|
2022
Q3 | $1.37M | Buy |
156,458
+140,242
| +865% | +$1.46M | ﹤0.01% | 942 |
|
|
2022
Q2 | $162K | Buy |
+16,216
| New | +$163K | ﹤0.01% | 1176 |
|
|
2021
Q3 | – | Sell |
-145,409
| Closed | -$2.19M | – | 1919 |
|
|
2021
Q2 | $2.19M | Sell |
145,409
-386,200
| -73% | -$5.8M | ﹤0.01% | 1323 |
|
|
2021
Q1 | $7.3M | Buy |
531,609
+69,036
| +15% | +$1.07M | 0.01% | 1004 |
|
|
2020
Q4 | $8.39M | Buy |
+462,573
| New | +$7.14M | 0.01% | 953 |
|
Arrowstreet Capital's PTVE Position: Q2 2025 in Review
Arrowstreet Capital sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 109,849 shares — an estimated $1.98M sold.
Arrowstreet Capital first reported a position in PTVE in Q4 2020 and held it in 13 quarters. The position peaked at $13.7M in Q1 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Arrowstreet Capital reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Arrowstreet Capital sold 109,849 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $1.98M.
- Arrowstreet Capital first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 13 quarters.
- Arrowstreet Capital's Pactiv Evergreen Inc. Common stock position peaked at $13.7M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Arrowstreet Capital's 13F filing for Q2 2025, filed 13 Aug 2025.